Crossmark Global Holdings
LKFT icon

Crossmark Global Holdings’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Crossmark Global Holdings’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$990K Buy
33,384
+22,846
+217% +$654K 0.01% 620
2026
Q2 		$316K Sell
10,538
-22,069
-68% -$627K ﹤0.01% 1041
2026
Q1 		$978K Sell
32,607
-370
-1% -$12.3K 0.01% 612
2025
Q4 		$1.08M Buy
32,977
+80
+0.2% +$2.58K 0.02% 577
2025
Q3 		$1.14M Sell
32,897
-14,545
-31% -$465K 0.02% 586
2025
Q2 		$1.33M Sell
47,442
-1,890
-4% -$50.7K 0.02% 537
2025
Q1 		$1.24M Buy
49,332
+169
+0.3% +$4.27K 0.02% 543
2024
Q4 		$1.35M Buy
49,163
+11,777
+32% +$328K 0.02% 490
2024
Q3 		$1.08M Buy
+37,386
New +$1.02M 0.02% 584
2021
Q2 		– Sell
-5,476
Closed -$422K – 1422
2021
Q1 		$422K Sell
5,476
-24
-0.4% -$2.21K 0.01% 997
2020
Q4 		$544K Buy
5,500
+530
+11% +$64.8K 0.01% 813
2020
Q3 		$705K Buy
4,970
+290
+6% +$48.3K 0.02% 644
2020
Q2 		$923K Buy
4,680
+294
+7% +$60.9K 0.03% 555
2020
Q1 		$859K Buy
4,386
+470
+12% +$101K 0.03% 505
2019
Q4 		$810K Sell
3,916
-204
-5% -$37.7K 0.02% 619
2019
Q3 		$629K Buy
+4,120
New +$675K 0.02% 701

Other funds holding LKFT

Gilead Sciences
Gilead Sciences Foster City, California $1.46B AUM 71.23% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
MQS Management
MQS Management New York $171M AUM 3.86% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
Evergreen Capital Management
Evergreen Capital Management Bellevue, Washington $5.65B AUM 21.62% 1-Year Est. Return
SignatureFD
SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Cacti Asset Management
Cacti Asset Management Atlanta, Georgia $1.89B AUM 58.55% 1-Year Est. Return

Crossmark Global Holdings's LKFT Position: Q3 2026 in Review

Crossmark Global Holdings increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 217% in Q3 2026, buying an estimated $654K and bringing the position to 33,384 shares worth $990K. The position accounts for 0.01% of the portfolio, ranked #620.

Crossmark Global Holdings first reported a position in LKFT in Q3 2019 and has held it in 16 quarters since. The position peaked at $1.35M in Q4 2024. 28 funds tracked by Wall St. Rank hold LKFT as of Q3 2026.

  • Crossmark Global Holdings held 33,384 shares of Lakefront Biotherapeutics American Depositary Shares worth $990K as of Q3 2026.
  • Crossmark Global Holdings bought 22,846 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2026, an estimated $654K.
  • Lakefront Biotherapeutics American Depositary Shares made up 0.01% of Crossmark Global Holdings's portfolio in Q3 2026, its #620 holding.
  • Crossmark Global Holdings first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2019 and has held it in 16 quarters since.
  • Crossmark Global Holdings's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.35M in Q4 2024.
  • 28 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2026.

Based on Crossmark Global Holdings's 13F filing for Q3 2026, filed 21 Oct 2026.